Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors

Cancer

Volumn 73, Issue 3 S, 1994, Pages 1076-1082

  Riva, Pietro ^a,c   Arista, Agostino ^b   Tison, Vittorio ^c   Sturiale, Carmelo ^a   Franceschi, Giancarlo ^a   Spinelli, Aureliano ^a   Riva, Nada ^a   Casi, Michela ^a   Moscatelli, Giovanni ^a   Frattarelli, Massimo ^b  

^a ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^b AO M Bufalini   (Italy)

^c BUFALINI HOSPITAL   (Italy)

Author keywords

brain tumor; malignant glioma; monoclonal antibodies; radioimmunotherapy; radioisotopes

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BC 2; MONOCLONAL ANTIBODY I 131; UNCLASSIFIED DRUG;

ADULT; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSIMETRY; DRUG DISTRIBUTION; DRUG HALF LIFE; GLIOBLASTOMA; HUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOIODINATION;

ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; GLIOMA; HUMAN; IODINE RADIOISOTOPES; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; RADIOIMMUNOTHERAPY; SUPPORT, NON-U.S. GOV'T;

EID: 0028013542     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940201)73:3+<1076::AID-CNCR2820731347>3.0.CO;2-Z     Document Type: Article

References (16)

1. Requirements for a treatment planning system for radioimmunotherapy
2. Overview of radioimmunotherapy: a European perspective
3. Antibody‐guided irradiation of hepatic metastases using intrahepatically administered radiolabelled anti‐CEA antibodies with simultaneous and reversible hepatic blood flood stasis using biodegradable starch microspheres
4. Intraperitoneal radioimmunotherapy with yttrium‐90‐labelled immunoconjugates
5. Locoregional immunotherapy of human ovarian cancer: preliminary results
6. Radioimmunotherapy of malignancies using antibody targeted radionuclides
7. Hexabrachion protein (tenascin, cytotactin, brachionectin) in connective tissues, embryonic brain and tumours
8. Tenascin: an exameric adhesive glycoprotein
9. Comparative analysis of the expression of the extracellular matrix protein “tenascin” in human normal fetal, adult and transformed tissues
10. Immunoscintigraphy of colorectal carcinoma with F(ab') fragments of anti‐CEA monoclonal antibody
11. Standardization of an immunoreactivity test for radiolabelled monoclonal antibodies
12. A simple qualitative determination of human antibodies to murine immunoglobulins (HAMA) in serum samples
13. Treatment of intracranial human glioblastoma by direct intratumoral administration of I‐131‐labelled antitenascin monoclonal antibody BC‐2